With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

Chief Customer Officer Lidia Rodriguez-Hupp on the importance of people skills and how Sentry’s 340B customers benefit from being part of The Craneware Group.

With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

With more contract pharmacy court rulings, CMS’ proposed remedy for Medicare Part B underpayments, and increased scrutiny from Congress, 2023 promises to be a big year for the 340B program.

Covered entities can expect scrutiny from Congress, more contract pharmacy restrictions from drugmakers, appeals court rulings, and a Part B payment remedy.

Gonzalez is The Craneware Group’s new 340B training manager. He oversees all customer training offerings available through the Sentry Success Community.